MoneyWorks4Me

Alembic Pharmaceuticals informs about company updates

28 Jan 2020 Evaluate
Alembic Pharmaceuticals has informed that the company has received US Food & Drug Administration (USFDA) Final approval for Azithromycin Tablets USP, 600 mg. The company has enclosed its press release.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..